Methadone Withdrawal when Starting an Antiretroviral Regimen Including Nevirapine
- 1 April 1999
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 19 (4) , 471-472
- https://doi.org/10.1592/phco.19.6.471.31046
Abstract
Antiretrovirals from three drug classes, nucleoside analogs, nonnucleoside analogs, and protease inhibitors, can be combined to achieve viral suppression. The nonnucleoside analog nevirapine is an inducer of cytochrome P450 3A4 liver metabolism and has interactions with protease inhibitors and oral contraceptives. Methadone has two roles in human immunodeficiency viral infection: pain management and treatment of opioid abuse. A drug‐drug interaction may result in decreased methadone blood levels when administered with nevirapine. A patient experienced methadone withdrawal symptoms when combining these agents.Keywords
This publication has 5 references indexed in Scilit:
- Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and AdolescentsAnnals of Internal Medicine, 1998
- Protease Inhibitors in Patients with HIV DiseaseClinical Pharmacokinetics, 1997
- Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humansJournal of Pharmacokinetics and Biopharmaceutics, 1996
- Involvement of Cytochrome P450 3A4 Enzyme in the N-Demethylation of Methadone in Human Liver MicrosomesChemical Research in Toxicology, 1996